Molecular Characterization of Hb Hamilton Hill (HBA2: c.388delC), a Novel HBA2 Variant Generating a Premature Termination Codon and Truncated HBA2 Chain

References

• Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 4th ed. Oxford, UK: Blackwell Science, 2001
   Google Scholar
• Harteveld CL, Higgs DR. α-Thalassaemia. Orphanet J Rare Dis. 2010;5(13). doi: 10.1186/1750-1172-5-13
   PubMed Web of Science ®Google Scholar
• Higgs DR. The molecular basis of alpha-thalassemia. Cold Spring Harb Perspect Med. 2013;3(1):a011718. doi: 10.1101/cschperspect.a011718
   PubMed Web of Science ®Google Scholar
• Vichinsky EP. α Thalassemia major – New mutations, intrauterine management, and outcomes. Hematology Am Soc Hematol Educ Program. 2009:35–41
   PubMedGoogle Scholar
• Fucharoen S, Viprakasit V. Hb H disease: Clinical course and disease modifiers. Hematology Am Soc Hematol Educ Program 2009:26–34
   PubMedGoogle Scholar
• Tan AS, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for α-thalassemia. Blood. 2001;98(1):250–251
   PubMed Web of Science ®Google Scholar
• Dode C, Rochette J, Krishnamoorthy R. Locus assignment of human α globin mutations by selective amplification and direct sequencing. Br J Haematol. 1990;76(2):275–281
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Versteegh FG, Kok PJ, et al. Hb Bleuland [α108(G15)Thr→Asn, ACC→AAC (α2)]: A new abnormal hemoglobin associated with a mild α-thalassemia phenotype. Hemoglobin. 2006;30(3):349–354
   PubMed Web of Science ®Google Scholar
• Qadah T, Finlayson J, Ghassemifar R. In vitro characterization of the α-thalassemia point mutation HBA2: c.95 + 1G > A [IVS-I-1(G > A) (α2)]. Hemoglobin. 2012;36(1):38–46
   PubMed Web of Science ®Google Scholar
• Qadah T, Finlayson J, Newbound C, et al. A molecular tool to assess the pathological relevance of α-globin DNA variants. Pathology. 2012;44(4):337–341
   PubMed Web of Science ®Google Scholar
• Higgs DR, Weatherall DJ. The α thalassaemias. Cell Mol Life Sci. 2009;66(7):1154–1162
   PubMed Web of Science ®Google Scholar
• Gell D, Kong Y, Eaton SA, et al. Biophysical characterization of the α-globin binding protein α-hemoglobin stabilizing protein. J Biol Chem. 2002;277(43):40602–40609
   PubMed Web of Science ®Google Scholar
• Feng L, Gell DA, Zhou S, et al. Molecular mechanism of AHSP-mediated stabilization of α-hemoglobin. Cell. 2004;119(5):629–640
   PubMed Web of Science ®Google Scholar
• Vasseur C, Domingues-Hamdi E, Brillet T, et al. The α-hemoglobin stabilizing protein and expression of unstable α-Hb variants. Clin Biochem. 2009;42(18):1818–1823
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Giordano PC, Losekoot M, et al. Hb Utrecht [α2 129(H12)Leu→Pro], a new unstable α2-chain variant associated with a mild α-thalassaemic phenotype. Br J Haematol. 1996;94(3):483–485
   PubMed Web of Science ®Google Scholar
• Darbellay R, Mach-Pascual S, Rose K, et al. Haemoglobin Tunis-Bizerte: a new α1 globin 129 Leu→Pro unstable variant with thalassaemic phenotype. Br J Haematol. 1995;90(1):71–76
   PubMed Web of Science ®Google Scholar
• Domingues-Hamdi E, Vasseur C, Fournier JB, et al. Role of α-globin H helix in the building of tetrameric human hemoglobin: Interaction with α-hemoglobin stabilizing protein (AHSP) and heme molecule. PLoS One. 2014;9(11):e111395. doi: 10.1371/journal.pone.0038505
   PubMed Web of Science ®Google Scholar
• Romao L, Inacio A, Santos S, et al. Nonsense mutations in the human β-globin gene lead to unexpected levels of cytoplasmic mRNA accumulation. Blood. 2000;96(8):2895–2901
   PubMed Web of Science ®Google Scholar
• Morgado A, Almeida F, Teixeira A, et al. Unspliced precursors of NMD-sensitive β-globin transcripts exhibit decreased steady-state levels in erythroid cells. PLoS One. 2012;7(6):e38505. doi: 10.1371/journal.pone.0038505
   PubMed Web of Science ®Google Scholar
• Khajavi M, Inoue K, Lupski JR. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet. 2006;14(10):1074–1081
   PubMed Web of Science ®Google Scholar
• Liebhaber SA, Coleman MB, Adams JG III, et al. Molecular basis for nondeletion α-thalassemia in American blacks. α2(116GAG—UAG). J Clin Invest. 1987;80(1):154–159
   PubMed Web of Science ®Google Scholar
• Finlayson J, Ghassemifar R, Holmes P, et al. Hb Lynwood [α107(G14) (–T) (α2) HBA2:c.323delT)] in conjunction with the α3.7 deletion produces a moderately severe α-thalassemia phenotype. Hemoglobin. 2011;35(2):142–146
   PubMed Web of Science ®Google Scholar